 David Saxon
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertriglyceridemia | 2 | 2024 | 45 | 1.010 |
Why?
| | Anti-Obesity Agents | 4 | 2025 | 67 | 0.950 |
Why?
| | Remote Consultation | 3 | 2021 | 66 | 0.870 |
Why?
| | Weight Loss | 4 | 2025 | 859 | 0.780 |
Why?
| | General Practice | 1 | 2023 | 32 | 0.740 |
Why?
| | Obesity | 7 | 2025 | 3118 | 0.710 |
Why?
| | Veterans | 5 | 2025 | 1639 | 0.690 |
Why?
| | Metabolic Syndrome | 2 | 2020 | 361 | 0.650 |
Why?
| | Medicine | 1 | 2021 | 125 | 0.570 |
Why?
| | Insulinoma | 1 | 2018 | 29 | 0.550 |
Why?
| | Confusion | 1 | 2018 | 30 | 0.540 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 140 | 0.530 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2025 | 2602 | 0.510 |
Why?
| | Cardiology | 1 | 2020 | 362 | 0.500 |
Why?
| | Delivery of Health Care | 2 | 2021 | 947 | 0.470 |
Why?
| | Quality Improvement | 1 | 2024 | 1296 | 0.460 |
Why?
| | Hypercholesterolemia | 1 | 2016 | 95 | 0.450 |
Why?
| | Insulin Antibodies | 1 | 2016 | 103 | 0.450 |
Why?
| | Rituximab | 1 | 2016 | 210 | 0.440 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 261 | 0.400 |
Why?
| | Cognition Disorders | 1 | 2018 | 544 | 0.400 |
Why?
| | Immunologic Factors | 1 | 2016 | 260 | 0.400 |
Why?
| | Glucagon-Like Peptides | 2 | 2025 | 71 | 0.390 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 444 | 0.360 |
Why?
| | Autoimmune Diseases | 1 | 2016 | 469 | 0.350 |
Why?
| | Cardiovascular Diseases | 3 | 2020 | 2190 | 0.340 |
Why?
| | Hypoglycemia | 1 | 2016 | 480 | 0.330 |
Why?
| | Referral and Consultation | 3 | 2023 | 868 | 0.330 |
Why?
| | Hypoglycemic Agents | 3 | 2022 | 1399 | 0.310 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 928 | 0.300 |
Why?
| | Blood Glucose | 4 | 2025 | 2344 | 0.290 |
Why?
| | Primary Health Care | 3 | 2024 | 1736 | 0.240 |
Why?
| | Humans | 29 | 2025 | 145750 | 0.230 |
Why?
| | Life Style | 2 | 2021 | 486 | 0.220 |
Why?
| | Blood Glucose Self-Monitoring | 2 | 2025 | 701 | 0.220 |
Why?
| | Insulin | 1 | 2016 | 2516 | 0.220 |
Why?
| | Gastric Balloon | 1 | 2024 | 17 | 0.210 |
Why?
| | Neural Stem Cells | 2 | 2023 | 168 | 0.210 |
Why?
| | Osteoporotic Fractures | 1 | 2025 | 62 | 0.210 |
Why?
| | Basolateral Nuclear Complex | 1 | 2023 | 11 | 0.200 |
Why?
| | Pancreatitis | 1 | 2024 | 146 | 0.200 |
Why?
| | Secondary Prevention | 1 | 2025 | 251 | 0.200 |
Why?
| | Veterans Health | 2 | 2021 | 190 | 0.180 |
Why?
| | Osteoporosis | 1 | 2025 | 239 | 0.180 |
Why?
| | Male | 15 | 2025 | 72992 | 0.180 |
Why?
| | Telephone | 1 | 2023 | 177 | 0.180 |
Why?
| | Chylomicrons | 1 | 2021 | 18 | 0.170 |
Why?
| | Obesity Management | 1 | 2021 | 12 | 0.170 |
Why?
| | Pastoral Care | 1 | 2021 | 2 | 0.170 |
Why?
| | Humanism | 1 | 2021 | 6 | 0.170 |
Why?
| | Cohort Studies | 3 | 2021 | 6032 | 0.160 |
Why?
| | Middle Aged | 9 | 2025 | 36297 | 0.160 |
Why?
| | Adult | 10 | 2025 | 40867 | 0.160 |
Why?
| | Capacity Building | 1 | 2021 | 62 | 0.160 |
Why?
| | Behavior Therapy | 2 | 2021 | 296 | 0.150 |
Why?
| | PPAR gamma | 1 | 2021 | 182 | 0.150 |
Why?
| | Specialization | 1 | 2021 | 137 | 0.150 |
Why?
| | Transgender Persons | 1 | 2023 | 210 | 0.150 |
Why?
| | Diabetes Mellitus | 2 | 2020 | 1101 | 0.150 |
Why?
| | Physicians, Primary Care | 2 | 2021 | 208 | 0.150 |
Why?
| | Mutagenesis, Insertional | 1 | 2019 | 68 | 0.150 |
Why?
| | Gene Targeting | 1 | 2019 | 81 | 0.150 |
Why?
| | Feeding Behavior | 1 | 2005 | 691 | 0.150 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 262 | 0.140 |
Why?
| | Transgenes | 1 | 2019 | 190 | 0.140 |
Why?
| | History, 21st Century | 1 | 2019 | 222 | 0.140 |
Why?
| | Metformin | 1 | 2022 | 329 | 0.140 |
Why?
| | Genetic Loci | 1 | 2019 | 267 | 0.140 |
Why?
| | Safety-net Providers | 1 | 2019 | 130 | 0.130 |
Why?
| | Aged | 7 | 2025 | 26212 | 0.130 |
Why?
| | Female | 13 | 2025 | 79025 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2021 | 554 | 0.130 |
Why?
| | Counseling | 1 | 2021 | 401 | 0.130 |
Why?
| | Hypolipidemic Agents | 1 | 2018 | 89 | 0.130 |
Why?
| | Colorado | 2 | 2024 | 4556 | 0.120 |
Why?
| | Pandemics | 2 | 2023 | 1711 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2025 | 11793 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 494 | 0.120 |
Why?
| | Telemedicine | 2 | 2025 | 963 | 0.120 |
Why?
| | Medication Therapy Management | 1 | 2016 | 72 | 0.110 |
Why?
| | Glioma | 1 | 2019 | 429 | 0.110 |
Why?
| | Elementary Particles | 1 | 2014 | 12 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2018 | 521 | 0.100 |
Why?
| | Quantum Theory | 1 | 2014 | 86 | 0.100 |
Why?
| | Exercise | 1 | 2005 | 2203 | 0.100 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 750 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2014 | 560 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2018 | 1211 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1331 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4090 | 0.080 |
Why?
| | United States | 3 | 2025 | 16122 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4569 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2770 | 0.070 |
Why?
| | Diagnostic Techniques, Neurological | 1 | 2007 | 11 | 0.060 |
Why?
| | Neurologic Examination | 1 | 2007 | 132 | 0.060 |
Why?
| | Diet, Atherogenic | 1 | 2005 | 6 | 0.060 |
Why?
| | Diabetic Neuropathies | 1 | 2007 | 100 | 0.060 |
Why?
| | Diphosphonates | 1 | 2025 | 68 | 0.050 |
Why?
| | Bone Density Conservation Agents | 1 | 2025 | 82 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2025 | 17322 | 0.050 |
Why?
| | Amygdala | 1 | 2023 | 200 | 0.050 |
Why?
| | Accidental Falls | 1 | 2025 | 228 | 0.040 |
Why?
| | Time | 1 | 2021 | 84 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2025 | 779 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2021 | 91 | 0.040 |
Why?
| | Affect | 1 | 2023 | 321 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 134 | 0.040 |
Why?
| | Homozygote | 1 | 2021 | 199 | 0.040 |
Why?
| | Electronics | 1 | 2021 | 65 | 0.040 |
Why?
| | Weight Gain | 1 | 2024 | 561 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 173 | 0.040 |
Why?
| | Efficiency | 1 | 2021 | 103 | 0.040 |
Why?
| | Heterozygote | 1 | 2021 | 314 | 0.040 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 88 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 515 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 10 | 0.040 |
Why?
| | Health Care Reform | 1 | 2021 | 109 | 0.040 |
Why?
| | United Kingdom | 1 | 2021 | 358 | 0.040 |
Why?
| | Schools, Medical | 1 | 2021 | 159 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 198 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 269 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 875 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2021 | 276 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 6084 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2021 | 463 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1270 | 0.030 |
Why?
| | Schools | 1 | 2021 | 449 | 0.030 |
Why?
| | Risk Factors | 2 | 2018 | 10916 | 0.030 |
Why?
| | Bariatric Surgery | 1 | 2021 | 253 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 927 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 741 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2447 | 0.030 |
Why?
| | Rural Population | 1 | 2022 | 660 | 0.030 |
Why?
| | Curriculum | 1 | 2023 | 1074 | 0.030 |
Why?
| | Endocrinology | 1 | 2016 | 77 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 380 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1048 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1751 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1652 | 0.030 |
Why?
| | Mesons | 1 | 2014 | 9 | 0.030 |
Why?
| | Mice | 2 | 2023 | 18357 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2019 | 2191 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2018 | 559 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 883 | 0.030 |
Why?
| | Electrons | 1 | 2014 | 80 | 0.020 |
Why?
| | Comorbidity | 1 | 2018 | 1662 | 0.020 |
Why?
| | Adolescent | 2 | 2023 | 22569 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2399 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2021 | 1101 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3551 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2967 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2933 | 0.020 |
Why?
| | Animals | 2 | 2023 | 38100 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5992 | 0.020 |
Why?
| | Sensory Thresholds | 1 | 2007 | 31 | 0.020 |
Why?
| | Diabetic Foot | 1 | 2007 | 25 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5921 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10089 | 0.020 |
Why?
| | Vibration | 1 | 2007 | 70 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11866 | 0.010 |
Why?
| | Child | 1 | 2021 | 22738 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3416 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2007 | 3937 | 0.000 |
Why?
|
|
Saxon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|